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Abstract: Polyphenols are an important class of phytochemicals, and several lines of evidence 
have demonstrated their beneficial effects in the context of a number of pathologies including 
neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. In this report, we 
review the studies on the effects of polyphenols on neuronal survival, growth, proliferation 
and differentiation, and the signaling pathways involved in these neurotrophic actions. Several 
polyphenols including flavonoids such as baicalein, daidzein, luteolin, and nobiletin as well as 
nonflavonoid polyphenols such as auraptene, carnosic acid, curcuminoids, and hydroxycinnamic 
acid derivatives including caffeic acid phentyl ester enhance neuronal survival and promote 
neurite outgrowth in vitro, a hallmark of neuronal differentiation. Assessment of underlying 
mechanisms, especially in PC12 neuronal-like cells, reveals that direct agonistic effect on tro-
pomyosin receptor kinase (Trk) receptors, the main receptors of neurotrophic factors including 
nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) explains the action 
of few polyphenols such as 7,8-dihydroxyflavone. However, several other polyphenolic com-
pounds activate extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase 
(PI3K)/Akt pathways. Increased expression of neurotrophic factors in vitro and in vivo is the 
mechanism of neurotrophic action of flavonoids such as scutellarin, daidzein, genistein, and 
fisetin, while compounds like apigenin and ferulic acid increase cyclic adenosine monophosphate 
response element-binding protein (CREB) phosphorylation. Finally, the antioxidant activity 
of polyphenols reflected in the activation of Nrf2 pathway and the consequent upregulation of 
detoxification enzymes such as heme oxygenase-1 as well as the contribution of these effects to 
the neurotrophic activity have also been discussed. In conclusion, a better understanding of the 
neurotrophic effects of polyphenols and the concomitant modulations of signaling pathways is 
useful for designing more effective agents for management of neurodegenerative diseases.
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Introduction
Polyphenolic compounds
Polyphenols are an important group of phytochemicals that are abundantly present 
in food sources.1 Several lines of evidence have demonstrated beneficial effects of 
these compounds in the context of several pathologies,2–8 and it has been repeatedly 
shown that consumption of foods rich in phenolic compounds can lower the risk of 
several diseases.9,10
Polyphenols have been reported to be of therapeutic value in neurodegen-
erative diseases,11–13 hypertension14 and other cardiovascular diseases,15 cancer,16–18 
inflammation,19,20 diabetes,21 dyslipidemia,22–24 allergy, and immune system diseases.25,26 
They have also been reported to have a role in the prevention of different types of cancer 
ranging from liver,4 prostate,27 and colorectal28 cancer to lymphoblastic leukemia.29
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Neurodegenerative disorders such as Alzheimer’s, 
Parkinson’s, and Huntington’s disease represent rapidly 
growing causes of disability and death, which have pro-
found economic and social implications; nonetheless, only 
few effective disease-modifying therapies are available for 
these diseases.30–32 Recent research has shown that certain 
polyphenols may have considerable neuroprotective effects 
in different brain pathologies including neurodegenerative 
diseases.8,11,33,34 Polyphenols from grape juice administered 
to older adult subjects have been shown to ameliorate the 
mild cognitive impairment.35 Similarly, Witte et al36 have 
shown that administration of resveratrol, a polyphenol pres-
ent in wine, in older adults significantly improves memory 
performance, indicating potential strategies to maintain 
brain health during aging. Assessment of cognitive per-
formance in middle-aged individuals has indicated that 
consumption of different polyphenols such as catechins, 
flavonols, and hydroxybenzoic acids is strongly associated 
with language and verbal memory.37 Other studies have also 
shown similar effects of other polyphenols on cognitive 
function and memory in older individuals, who are at risk 
for neurodegenerative diseases.38,39 In another human study, 
epigallocatechin–gallate (EGCG) significantly improved 
cognitive deficits in individuals with Down syndrome.40
Several studies have demonstrated that different poly-
phenolics with neuroprotective activity, such as EGCG,41,42 
epicatechin,43 curcumin,44 resveratrol,45 quercetin,46 and 
citrus flavonoids (naringenin and hesperetin),47 are able to 
cross the blood–brain barrier and therefore indicate that 
these compounds localize within the brain tissue and may 
well exert neuroprotective and neuromodulatory actions in 
the settings of different brain pathologies.
Polyphenolic compounds can be classified into different 
groups as described in Figure 1.1 Among them, flavonoids 
constitute a major subgroup, which are highly present 
in fruits and vegetables and possess several biological 
activities.1
Polyphenols have been extensively studied for their 
antioxidant action48–52 and some of their beneficial effects, 
including neuroprotective activity, have been attributed to 
this capacity.53–55 The neuroprotective effect of polyphenols 
against the diseases of nervous system has also been addressed 
in a number of studies.56–59 The aim of this review, however, 
is to extensively address the alterations of signaling pathways 
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Figure 1 Main classes of polyphenols and their chemical structures.
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involved in the neurotrophic action of polyphenols that lead 
to neuronal survival, growth, proliferation, and differentia-
tion. The other aspects of neuroprotective activity of these 
compounds, which are mainly ascribed to the antioxidant 
action and mitigation of oxidative stress, have been reviewed 
elsewhere5,7,8,60–62 and are only briefly mentioned here. It 
should also be mentioned that in in vitro studies, which are 
the main focus of this report, supraphysiological doses of 
polyphenols may have been used and, therefore, caution 
should be exerted in extrapolation of these data to in vivo 
conditions.56 The structures of some of the most highly studied 
neurotrophic polyphenols are depicted in Figures 2 and 3.
Neurotrophic effects of polyphenols: 
enhancement of survival in neuronal cells
Survival signaling is important to suppress the cell death 
machinery and counterbalance apoptotic signaling in 
the nervous system.63 Several studies have shown that 
polyphenolic compounds enhance neuronal survival in 
serum-deprived conditions. Lin et al64 showed that in neu-
ronal-like PC12 cells, luteolin (3′,4′,5,7-tetrahydroxyflavone, 
Figure 2) attenuates serum withdrawal-induced cytotoxicity. 
Other examples of neuroprotectants that exerted prosurvival 
action in PC12 cells include curcuminoids, the predominant 
polyphenolic compounds of Curcuma longa Linn.;65 EGCG 
(Figure 2), the major polyphenol of green tea extract;66 caffeic 
acid phenethyl ester (CAPE, Figure 3), an active component 
of propolis;67 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone 
(HHMF) from the Citrus genus; and nobiletin (Figure 2), 
the most abundant polymethoxyflavone in orange peel 
extract.68 Furthermore, other investigators have shown 
that treatment with genistein and daidzein (Figure 2), iso-
flavones present in soybeans and soy products, enhances 
proliferation and survival of the hippocampal neuronal cells.69 
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Figure 2 Chemical structures of flavonoids with neurotrophic activity.
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In addition, application of 7,8-dihydroxyflavone (7,8-DHF, 
Figure 2), a flavone, promotes survival of cultured motoneu-
rons, spiral ganglion neurons (SGNs), and hippocampal 
neuronal cells.70 In another study, the protective ability 
of quercetin (3,3′,4′,5,7-pentahydroxyflavone, Figure 2) 
on P19-derived neurons was determined.71 Ferulic acid 
(4-hydroxy-3-methoxycinnamic acid, Figure 3) was able 
to significantly increase the survival of neural stem/pro-
genitor cells (NSC/NPCs) cultured from rat embryo, and 
also increased the number and size of secondary formed 
neurospheres.72
Promotion of neurite outgrowth in 
neuronal cells
Neurite outgrowth is a crucial step in the differentiation of 
neurons, which begins at the cell body and extends outward to 
form functional synapses. In response to extracellular signals, 
the growth of neurite processes starts, involving the addition of 
new plasma membranes, generation of new cytoplasm, and the 
continued expansion and modification of the cytoskeleton.73 
A number of neurotypic proteins have been associated with 
neurite outgrowth, including growth-associated protein 43 
(GAP-43), microtubule-associated protein (MAP) and tau, 
as well as presynaptic membrane-associated proteins, such as 
synaptophysin and synapsin.74 Many polyphenolic compounds 
from natural and synthetic sources have been demonstrated to 
induce neurite outgrowth in various primary neuronal cultures 
and neuronal cell lines (Table 1).
Several studies have shown that different polyphenols 
including flavonoids such as genistein,75 quercetin, liquiritin 
from Glycyrrhizae radix plant (Figure 2),76 isorhamnetin 
(a flavonolaglycone from Ginkgo biloba plant, Figure 2),77 
and acetylated flavonoid glycosides from Scopariadulcis78 
as well as the stilbenoid compound resveratrol (a polyphenol 
present in grapes and red wine, Figure 3)79 cause a significant 
enhancement of neurotrophin (nerve growth factor [NGF] 
and brain-derived neurotrophic factor [BDNF])-mediated 
neurite outgrowth in PC12 cells.
Some of the phenolic compounds are capable of enhanc-
ing the expression levels of the differentiation markers 
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Figure 3 Chemical structures of polyphenols with neurotrophic activity that do not belong to the group of flavonoids.
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(GAP-43, neurofilament light subunit, synaptophysin, 
synapsin, etc). Flavonoids that are capable of causing such 
an effect include luteolin,64 daidzein,80 7,8-DHF,81 citrus 
HHMF,68 puerarin (an isoflavone),82 CAPE,67 curcuminoids,65 
tectoridin (an isoflavone from Belamcandachinensis plant), 
hesperidin (a flavanone glycoside from the genus Citrus of 
plants), and also flavonols including kaempferol, quercetin, 
and isorhamnetin.77
The neuropathy induced by chemotherapeutic agents such 
as cisplatin is an important side effect of these drugs.83,84 
Two polyphenolic compounds, in separate studies, have 
been tested to block or reverse the cisplatin-induced neurite 
toxicity in PC12 cells. Phenoxodiol (2H-1-benzopyran-7-
0,1,3-[4-hydroxyphenyl]), a compound related to genistein, 
showed significant neurite-protective effects against cis-
platin at 1 μM, a concentration that was not toxic to the 
PC12 cells.85,86 Curcumin (Figure 3) has also shown similar 
protective effects against cisplatin-induced neurite toxicity 
in PC12 cells. Moreover, curcumin did not interfere with 
the cisplatin’s antitumor mode of action as assessed in vitro 
in HepG2 cells.87
Activation of tropomyosin receptor 
kinases
Mammalian neurotrophins including NGF, BDNF, neurotro-
phin 3 (NT3), and neurotrophin 4 (NT4) play major roles in 
development, maintenance, repair, and survival of specific 
neuronal populations.88–90 Several lines of evidence indicate 
that decreased functioning of neurotrophins and their receptors 
can lead to neuronal injury and contribute to the pathogenesis 
of neurodegenerative diseases.30,91,92 Thus, neurotrophins and 
bioactive compounds capable of activation of neurotrophin 
receptors have great potential for management of neurodegen-
erative diseases and other neurological disorders.93,94
Neurotrophins interact with two principal receptor 
types: p75NTR and the tropomyosin receptor kinase (Trk) 
receptors consisting of three receptors of TrkA, TrkB, and 
TrkC in mammals (also known as Ntrk1, Ntrk2, and Ntrk3).95 
Different patterns of Trk receptors’ expression exist through-
out the mammalian brain and peripheral nervous system. 
TrkA is highly expressed in cholinergic neurons in the basal 
forebrain and also the peripheral nervous system, while TrkB 
and TrkC are highly expressed in the hippocampus.96 These 
transmembrane receptors belonging to the group of receptor 
tyrosine kinases (RTKs) and the larger family of catalytic 
receptors include an extracellular neurotrophin-binding 
domain and an intracellular tyrosine kinase domain.92,97 
NGF has a higher binding rate with TrkA, while BDNF and 
NT-4/5 bind with TrkB, and finally, NT-3 is the main ligand 
for TrkC receptor, with a lower affinity for TrkA and TrkB.98 
The neurotrophins-induced dimerization of the Trk receptors 
leads to activation through transphosphorylation of the cyto-
plasmic domain kinases and stimulates three major signal-
ing pathways: phoshpatidyloinositol-3-kinase (PI3K)/Akt, 
mitogen-activated protein kinase (MAPK), and phospholipase 
C-γ1.92 Downstream signaling principally promotes survival, 
growth, and neuronal differentiation and mediates neurogen-
esis and plasticity in many neuronal populations.99–101
There are only few polyphenolic compounds that act 
as direct agonists of Trk receptors and mimic the binding 
of neurotrophins, while several others stimulate the more 
downstream pathways leading to the neurotrophic effect 
(discussed in the following sections). 7,8-DHF provokes 
TrkB dimerization and tyrosine phosphorylation and acti-
vates downstream Akt and extracellular signal-regulated 
kinase (ERK) as potently as BDNF. 7,8-DHF also inhibits 
neuronal death in T48, a stably transfected TrkB murine 
cell line, and hippocampal neurons, and its activity can be 
inhibited by K252a, a Trk receptor antagonist.102 In another 
study, 7,8-DHF strongly activated TrkB receptor and its 
downstream Akt and ERK1/2 pathways, prevented cell death, 
and promoted neuritogenesis in the retinal ganglion cells.103 
It was also shown in a later report that 7,8-DHF as a BDNF 
agonist causes phosphorylation of TrkB receptors and stimu-
lates survival and neurite growth of cultured motoneurons: 
PI3K/Akt but not MAPK pathway was responsible for the 
survival and growth promoting effects of 7,8-DHF,70 which 
is apparently different from MAPK activation mediated by 
7,8-DHF in hippocampal neurons.102
Furthermore, 7,8,3′-trihydroxyflavone, a compound 
related to 7,8-DHF, has shown similar effects on the survival 
of SGNs, phosphorylation of TrkB receptor, and ERK.104 
Diosmetin, another polyphenol compound belonging to 
flavonoids class of polyphenols, has also shown antiapop-
totic effects, but it induces only weak phosphorylation of 
TrkB. Diosmetin also increased the phosphorylation of Akt 
and ERK.102 Another flavonoid, epicatechin, restores TrkA 
phosphorylation in diabetic animals and reduces diabetes-
induced neuronal cell death. It also blocks diabetes-induced 
p75NTR expression and p75NTR apoptotic pathway in vivo 
and in Müller cells.105
Modulation of expression of 
neurotrophic factors and Trk receptors
Several polyphenols increase the expression levels of neu-
rotrophins and Trk receptors (Table 2). Scutellarin, isolated 
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from the traditional Chinese herb, Erigeron breviscapus 
(Figure 2), alpinetin of the genus Alpinia, and also luteolin, 
calycosin, genistein, and isorhamnetin effectively upregulate 
the synthesis and release of NGF, glial cell line-derived 
neurotrophic factor (GDNF), and BDNF.106,107 The capac-
ity of luteolin, genistein, calycosin, and isorhamnetin in 
increasing the expression of neurotrophins was mediated 
through estrogen signaling pathways. In the estrogen receptor 
(ER)-dependent pathway, the phosphorylated ER dimer was 
demonstrated to elevate the BDNF messenger RNA levels.108 
Scutellarin induced the expression of neurotrophins’ mes-
senger RNAs and proteins through cyclic adenosine mono-
phosphate response element-binding protein (P-CREB) and 
p-Akt signaling in primary rat astrocytes.106
Several polyphenolic compounds have been reported to 
increase BDNF levels; different flavonoids such as baicalein 
(5,6,7-trihydroxyflavone, Figure 2),109 butein and fisetin of 
Rhusverniciflua (Figure 2),110 chrysin (5,7-dihydroxyflavone, 
Figure 2),111 daidzein and genistein,112 3,5,6,7,8,3′,4′-
heptamethoxyflavone (HMF),113 oroxylin A (5,7-dihidrixy-
6-methoxyflavone, Figure 2),114 puerarin,115 and quercetin,116 
as well as other polyphenols such as CAPE,117 curcumin,118 
and resveratrol,79,119–122 have been reported to possess this 
property.
The aforementioned studies have examined BDNF levels 
under various experimental conditions. Some of the poly-
phenolic compounds, including fisetin and baicalin, one of 
the major flavonoids isolated from the roots of Scutellaria 
Baicalensis Georgi could activate the ERK-CREB pathway 
and exhibited memory-enhancing effects through the activa-
tion of CREB-BDNF pathway in the hippocampus of a mouse 
model of amnesia induced by scopolamine.109,110 In another 
study, chrysin was shown to rescue memory impairment and 
BDNF reduction caused by aging in mice.111
Other studies have demonstrated the increased BDNF 
expression and neuroprotective effects of polyphenolic 
compounds in the settings of in vitro and in vivo mod-
els of ischaemia-, 6-hydroxydopamine (6-OHDA)-, or 
amyloid-β (Aβ)-mediated injury.113,115,118,123,124 For example, 
HMF enhances BDNF production in astrocytes and induces 
neurogenesis in the hippocampus after brain ischemia, 
which is mediated by the activation of ERK1/2 and CREB 
pathways.113 Puerarin has also a protective effect in 6-OHDA-
lesioned rats by modulating BDNF expression and activation 
of the nuclear factor E2-related factor 2/antioxidant response 
element (Nrf2/ARE) signaling pathway.115 Curcumin, on 
the other hand, was able to block BDNF reduction in the 
Aβ-infused rats through Akt/GSK-3β signaling pathway.118 
Antiamnesic and protective effects of luteolin against Aβ 
toxicity in mice was associated with the increase of BNDF as 
well as TrkB expression in the cerebral cortex of mice.123
Many polyphenolic compounds have antidepressant 
effects that are associated with increased BDNF levels.125,126 
Xiaochaihutang, a mixture of seven Chinese herbs that is 
traditionally used in People’s Republic of China for treatment 
of depressive-like symptoms, considerably increased BDNF, 
NGF, TrkB, and TrkA expressions in the hippocampus and 
also improved depression-like behaviors in chronic unpre-
dictable mild stress (CUMS) model in rats.127 A flavanonol 
compound, astilbin, reverses depressive-like behaviors in 
a mouse model of depression and its effect is mediated by 
the upregulation of BDNF and activation of ERK and Akt 
pathways.128 Antidepressant effects of baicalein, resveratrol, 
and rosmarinic acid (a caffeic acid ester) are also mediated 
by BDNF-ERK-mediated neurotrophic action.129–131 Another 
polyphenol, ferulic acid, not only increases the proliferation 
of NSC/NPCs in vitro and in vivo but also produces an addi-
tive antidepressant-like effect in corticosterone-treated mice, 
mediated by CREB-BDNF signaling pathway.72 Also, chrysin 
improves age-related memory decline in mice, an effect that 
is probably related to the modulation of BDNF production 
and free radical scavenging action of this compound.111
ERK pathway activation
Modulation of neuronal survival signaling pathways may 
represent a promising approach to the management of 
central nervous system diseases. Several pathways includ-
ing ERK1/2 and PI3K promote cell survival in the nervous 
system as well as other tissues.132,133 Recently, the ERK 
pathway, a part of MAPKs, has been implicated in several 
physiological functions of neurons, including proliferation, 
differentiation, survival, and regulation of response to vari-
ous growth factors.134–138 The activation of ERK1/2 requires 
phosphorylation of threonine and tyrosine residues that is 
carried out by the upstream activator kinase, mitogen-acti-
vated protein kinase kinase (MEK). Activated ERK1/2 then 
changes its localization and phosphorylates different target 
molecules, including transcription regulators and cytoskeletal 
proteins (Figure 4).139,140
ERK1/2 activation by some of the polyphenolic com-
pounds promotes survival and antiapoptotic signaling in 
various cell lines (Table 3). It has been shown that ERK1/2 
activation by luteolin protects PC12 cells against apoptosis. 
Furthermore, the cell viability of PC12 cells that were pre-
treated with U0126, a specific inhibitor of ERK1/2 kinase, 
was significantly reduced.64
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Activation of the ERK1/2 pathway has mediated the 
neuroprotective activity against damaging insults.132 Aβ 
peptide can cause a significant decrease in cell viability and 
neurite outgrowth and can induce apoptosis in neuronal cells. 
Liquiritin’s protection against Aβ-induced neuronal apoptosis 
and its effect on the differentiation of rats’ primary cultured 
hippocampal neurons were inhibited with a MAPK inhibi-
tor.141 Similarly, in another study, the decreased cell viability 
induced by Aβ
25–35
 was reported to be blocked by icaritin 
(a prenyl flavonoid derivative from Chinese tonic herb Epime-
dium). A blocker of ERK/MAPK pathway weakened this pro-
tective effect, which implied that ERK1/2 pathway is involved 
in the neuroprotective action of icaritin.142 Likewise, rutin 
(3,3′,4,5,7-pentahydroxyflavone-3-rhamnoglucoside) has also 
shown beneficial effects against Aβ-induced neurotoxicity in 
rats through the activation of MAPK and BDNF.143
As already mentioned, ERK1/2 signaling is crucial 
for neuronal differentiation and activation of associated 
cytoskeletal and synaptic proteins. It has been found that 
luteolin increases neurite outgrowth and expression of 
GAP-43 protein, a neuronal differentiation biomarker, and 
also heme oxygenase-1 (HO-1) expression in PC12 cells. All 
these effects could be blocked by pharmacological inhibi-
tion of ERK1/2.64 In another report, it was established that 
luteolin induced microRNA-132 expression in PC12 cells 
and induced neurite outgrowth, while these effects were sup-
pressed by protein kinase A (PKA) and MEK1/2 inhibitors, 
but not by protein kinase C (PKC) inhibitors.144
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Figure 4 Main signaling pathways that mediate the neurotrophic effects of various polyphenols.
Notes: By activation of the Trk receptors, neurotrophic signaling starts mainly through the Ras/MAPK, PI3K/Akt, and PL-Cγ pathways. Trk binding by polyphenols results 
in the autophosphorylation and activation of these receptors. Receptor phosphorylation forms adaptor-binding sites that couple the receptor to MAPKs, PI3K, and 
phospholipase Cγ (PLCγ1) pathways, which ultimately result in the phosphorylation of CReB protein. Phosphorylated CReB bound to the CBP leads to the increased 
transcription of target genes by binding to CRe. These genes are involved in survival, differentiation, growth, synaptic plasticity, and long-term memory. Polyphenols-eR 
binding also activates neurotrophic effects via PKC pathways. 1: Epicatechin, 2: 7,8,3’-trihydroxyflavone, 3: diosmetin 4: 7, 8-dihydroxyflavone, 5: daidzein, 6: resveratrol, 
7: hesperetin, 8: curcuminoids, 9: caffeic acid phenethyl ester, 10: ferulic acid, 11: baicalein, 12: apigenin, 13: honokiol, 14: nobiletin, 15: pinocembrin, 16: astilbin, 17: 
artepillin C, 18: 3,5,6,7,8,3′,4′-heptamethoxyflavone, 19: 4′-O-β-D-glucopyranosyl-30,4-dimethoxychalcone, 20: fustin, 21: puerarin, 22: scutellarin, 23: oroxylin A, 24: methyl 
3,4-dihydroxybenzoate, 25: carnosic acid, 26: rosmarinic acid, 27: luteolin, 28: auraptene, 29: epigallocatechin-3-gallate, 30: icaritin, 31: liquiritin, 32: fisetin, 33: rutin.
Abbreviations: CaMK, Ca2+-calmodulin kinase; CReB, cyclic adenosine monophosphate response element-binding protein; CBP, CReB-binding protein; DAG, diacylglycerol; 
ER, estrogen receptor; ERK, extracellular signal-regulated kinase; IP3, inositol trisphosphate; MAPK, mitogen-activated protein kinase; MEK, mitogen-activated protein kinase 
kinase; PI3K, phosphatidylinsoitol-3-kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ; Trk, tropomyosin receptor kinase.
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Table 3 Neuronal survival and differentiation induced by polyphenols and contribution of different neurotrophic pathways to these 
effects
Compound Cell model Activation of pathway References
MEK/ERK1/2 PI3K/Akt PLCγ –PKC
Artepillin C PC12m3 cells Y –a – 145
Auraptene PC12 cells Y – – 151
Baicalein C17.2 NSCs Y – – 196
Caffeic acid phenethyl ester Rat organotypic midbrain slice cultures Y – – 117
Carnosic acid PC12 cells Y Y – 184
Carnosic acid PC12 cells Y – – 200
Curcuminoids PC12 cells Y – Y 65
Daidzein Primary rat DRG neuronal cultures Y – Y 69
7,8-Dihydroxyflavone Mouse hippocampal cultures and mouse 
embryonic motoneuron cultures
N Y – 70
7,8-Dihydroxyflavone Retinal ganglion cell cultures Y Y – 103
4′-O-β-d-Glucopyranosyl-3′, 
4-dimethoxychalcone
PC12 Cells Y N – 201
HMF Mouse neuronal cells Y – – 113
Hesperetin PC12 cells Y Y Y 153
Luteolin PC12 cells Y – Y 64
Luteolin PC12 cells Y – – 144
Methyl 3,4-
dihydroxybenzoate
Rat cortical neuronal cultures – Y – 147
Nobiletin PC12D cells Y – – 152
Oroxylin A Cortical neuronal cultures – Y – 114
Puerarin PC12 cells Y Y – 82
Resveratrol Astrocytes cultures Y – – 119
Rosmarinic acid PC12 cells Y – – 200
Note: aNot determined.
Abbreviations: N, activation of the pathway is not involved; Y, activation of the pathway is involved; DRG, dorsal root ganglion; ERK, extracellular signal-regulated kinase; 
HMF, 3,5,6,7,8,3′,4′-heptamethoxyflavone; MEK, mitogen-activated protein kinase kinase; NSCs, neural stem cells; PKC, protein kinase C; PLCγ, phospholipase Cγ.
Lin et al64 have shown the involvement of both ERK 
and PKC signaling pathways in PC12 neurite outgrowth. 
Similarly, the involvement of the ERK and PKC signaling 
pathways in the process of neuritogenesis in PC12 cells was 
demonstrated in response to curcuminoids.65 In another study, 
artepillin C-induced neurite outgrowth of PC12m3 cells has 
been shown to be inhibited by the ERK and p38 MAPK inhibi-
tors. On the other hand, inhibition of ERK by U0126 entirely 
blocked artepillin C-mediated p38 MAPK phosphorylation 
of PC12m3 cells. It was suggested that the activation of p38 
MAPK through the ERK signaling pathway is responsible 
for the artepillin C-induced neurite outgrowth of PC12m3 
cells.145 Finally, fisetin has been very effective in induction of 
PC12 cell differentiation, while MEK inhibitors considerably 
decreased fisetin-induced ERK activation and neurite out-
growth.146 The different neurotrophic effects of polyphenols 
involving the ERK pathway are listed in Tables 1, 3–5.
PI3K pathway activation
A number of studies have demonstrated that PI3K and its 
downstream effector Akt are involved in neuronal survival 
and increased neurite outgrowth as well as other neu-
rotrophic effects of polyphenols82,106,118,128,147 (Tables 1, 3–5). 
In this regard, Hoppe et al118 showed that PI3K/Akt path-
way is involved in curcumin-mediated neuroprotection in 
Aβ-induced cognitive impairment in rats. Similarly, scutel-
larin is reported to protect neurons against hypoxia by increas-
ing neurotrophins through pCREB and pAkt signaling, but 
not MAPKs.106 In cultured primary cortical neurons, methyl 
3,4-dihydroxybenzoate, a phenolic acid derivative, promoted 
neuronal survival and neurite outgrowth via PI3K/Akt signal-
ing pathway, and these effects could be inhibited by a PI3K-
specific inhibitor.147 In another report, evidence was provided 
that oroxylin A increased BDNF production and neuronal 
differentiation in primary cortical neurons by activation of 
the Akt pathway. Puerarin also protected dopaminergic cells 
and potentiated the effect of NGF on neuritogenesis in PC12 
cells via activation of the ERK1/2 and PI3K/Akt pathways.82 
Finally, astilbin, a natural flavonoid, has been demonstrated to 
reduce depressive-like behaviors in mice models of depression 
by activation of the MAPK/ERK and PI3K/Akt pathways that 
are the downstream signaling pathways of BDNF.128
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Table 4 improvement of memory and modulation of other brain functions in animal models by polyphenols and involvement of 
neurotrophic signaling pathways
Compound Animal model Effect on brain function Involved signaling pathways References
MEK/ERK1/2 PI3K/Akt PLCγ–PKC
Apigenin Mice improvement of learning and 
memory in APP/PS1 mice
Y –a – 157
Baicalein Mice Memory enhancement Y – – 109
Baicalein Mice Prevention of spatial learning 
and memory deficits following 
irradiation
Y – – 109,155
Curcumin Rats improvement of amyloid-β-induced 
cognitive impairment
– Y – 118
Ferulic acid Mice Antidepressant-like effect Y Y Y 202
Fisetin Mice Memory enhancement Y – – 110,203
HMF Mice enhancement of neurogenesis after 
brain ischemia
Y – – 113
Nobiletin Mice improvement of memory in 
olfactory-bulbectomized mice
Y – – 152
Pinocembrin Mice Improvement of cognitive deficits 
in APP/PS1 mice
Y – – 158
Resveratrol Mice improvement of hippocampal 
atrophy in chronic fatigue 
syndrome mice
Y – – 122
Rutin Rats Memory enhancement Y – – 143
Note: aNot determined.
Abbreviations: Y, activation of the pathway is involved; ERK, extracellular signal-regulated kinase; HMF, 3,5,6,7,8,3′,4′-heptamethoxyflavone; MEK, mitogen-activated 
protein kinase kinase; PKC, protein kinase C; PLCγ, phospholipase Cγ.
Phosphorylation of CReB
Cyclic AMP response element (CRE) sequence is found in 
the regulatory region of several genes. CREB is a transcrip-
tion regulator that recognizes CRE sequence and activates 
gene transcription, a process believed to play an important 
role in learning and memory in the brain. In neuronal cells, 
activation of the CREB pathway by neurotrophic factors 
such as NGF leads to the expression of genes that regulate 
survival, growth, synaptic plasticity, differentiation, dendritic 
spine formation, and long-term memory.148,149
Mantamadiotis et al150 provided evidence that mice lacking 
CREB function in the brain showed neurodegenerative pro-
cess in the hippocampus and dorsolateral striatum. Consider-
ing the importance of this pathway in the nervous system, we 
hereby summarize the studies on some phenolic compounds 
that activate CREB pathway and discuss their possible thera-
peutic effects in neurodegenerative diseases (Figure 4).
Luteolin,144 auraptene (a coumarin derivative, Figure 3),151 
curcumin and demethoxycurcumin,65 nobiletin,152 hesperetin 
(a flavonoid),153 and citrus HHMF68 have all been shown to 
increase CREB phosphorylation in PC12 cells. Chai et al106 
have also suggested that one of the signaling pathways related 
to neuroprotective effect of scutellarin is pCREB, which 
stimulates the production and release of neurotrophic factors 
in primary rat astrocyte cultures.
Resveratrol has shown neurotrophic effect in dopaminergic 
neurons79 and antidepressant-like effects in rats via activation 
of CREB in the hippocampus and amygdala.130 In a study by 
Li et al,154 green tea catechins-treated mice showed signifi-
cantly higher CREB phosphorylation than the aged control 
mice. Ferulic acid has also been reported to increase CREB 
phosphorylation in the hippocampus of corticosterone-treated 
mice.72 In an animal model of traumatic brain injury, 7,8-DHF 
restores the levels of significantly reduced CREB phospho-
rylation.81 Baicalein increased pCREB in the hippocampus 
of mice109 and also in NPC.155 Administration of baicalein 
to rats with cognitive impairment induced by corticosterone 
significantly improved memory-associated decrease in the 
expression levels of BDNF and CREB proteins in the hip-
pocampus of these animals.156 Activation of CREB by apigenin 
(4′,5,7-trihydroxyflavone, Figure 2)157 and pinocembrin 
(5,7-dihydroxyflavanone)158 was seen in transgenic Alzheimer’s 
disease mouse model. Finally, rutin and fustin flavonoids have 
been demonstrated to increase the expression of CREB in 
the hippocampi of rats and to attenuate Aβ-induced learning 
impairment in mice, respectively.143,159
Antioxidant activity
The CNS is unique in its high susceptibility to oxidative 
stress, which is a result of its high oxygen consumption 
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and also the presence of large amounts of fatty acids and 
metals.160 Several lines of evidence suggest that oxidative 
stress is involved in the pathogenesis of neurodegenerative 
disorders such as Alzheimer’s and Parkinson’s disease.61,161 
The antioxidant effect of polyphenols has long been studied 
as a mechanism of their neuroprotection against neurode-
generative disorders61,162 and other neurological diseases.163 
Although the direct interaction of polyphenols with reactive 
oxygen species (ROS) does not seem to be very likely to hap-
pen in vivo as a main mechanism of action, their antioxidant 
effects are most probably exerted through other mechanisms 
such as activation of Nrf2 pathway, upregulation of anti-
oxidant enzymes, induction of hypoxia signal transduction 
(HIF-1-α pathway), and interaction with metal ions as sources 
of ROS.12,161,164
For example, EGCG165 and resveratrol166 have been 
reported to exert their neuroprotective action through 
activation of the HIF-1 pathway. Mangiferin and morin 
(3,5,7,2′,4′-pentahydroxyflavone) revealed considerable 
antioxidant and antiapoptotic properties through the activa-
tion of antioxidant enzymes.167
Protection against damage induced by 
neurotoxins
Cellular, biochemical, and animal studies have shown that 
Aβ is a crucial factor in the pathogenesis of Alzheimer’s 
disease.168,169 There are several reports suggesting that some 
polyphenols protect neuronal cells against Aβ-induced neu-
ronal cell death or other forms of neuronal injury (Table 5). 
For instance, icaritin was shown to protect primary rat cortical 
neuronal cells against apoptosis induced by Aβ
25–35
 insult.142 
Similarly, Ushikubo et al170 demonstrated that 3,3′,4′,5,5′-
pentahydroxyflavone prevents Aβ fibril formation and that 
lowering fibril formation decreases Aβ-induced cell death in 
rat hippocampal neuronal cells. In another study, ursolic acid, 
p-coumaric acid, and gallic acid extracted from Cornifructus 
plant were shown to attenuate apoptotic features such as 
morphological nuclear changes, DNA fragmentation, and 
cell blebbing induced by Aβ peptide in PC12 cells.171 The 
major flavonoids of cocoa, epicatechin and catechin, protect 
PC12 cells from Aβ-induced neurotoxicity.172 Carnosic acid 
(Figure 3), a highly bioactive phenolic compound found in 
rosemary (Rosmarinus officinalis), and liquiritin have shown 
a protective effect against Aβ in SH-SY5Y human neuro-
blastoma cells and primary cultured hippocampal neurons, 
respectively.141,173
6-OHDA is a compound used to induce a Parkinson-
like pathology in vitro and in vivo. It has been reported that 
baicalein174 and also ferulic acid and caffeic acid derivatives, 
both belonging to hydroxycinnamic acid family (Figure 1),60 
protect neuronal SH-SY5Y cells against 6-OHDA.
Hydrogen peroxide is an ROS that has been shown to 
induce neuronal cell damage in experimental models.175 
It has been shown that several polyphenols such as quercetin 
in cultured neuronal precursor cells,176 7,8-DHF in retinal 
ganglion and RGC-5 cells,103 and caffeic acid esters in PC12 
cells53 are able to exert protective effects against ROS. In 
addition, other authors suggest that the neuroprotective 
effects of 7,8-DHF are mediated by its ability to scavenge 
ROS and increase cellular glutathione levels.55
Other neurotoxins have also been applied to produce 
experimental models to assess the neuroprotective capac-
ity of polyphenolic compounds. CAPE protects PC12 
cells against dopaminergic neurotoxin MPP+ (1-methyl-4-
phenylpyridinium).67 Administration of 7,8-DHF prevented 
neuronal death in mouse brain induced by kainic acid.102 
Icariin is another polyphenol compound that protects 
primary cultured rat hippocampal neuronal cells against 
corticosterone-induced apoptosis.177 In addition, baicalein 
was also shown to inhibit necrotic cell death damage in NPCs 
and to attenuate impairment of hippocampal neurogenesis 
caused by irradiation.155
Polyphenols have also shown therapeutic potential in 
animal models of neurodegenerative diseases induced by 
various neurotoxins. In an Aβ-induced amnesia model in 
mice, oral administration of luteolin mitigated learning and 
memory impairment.123 Curcumin has also been shown to 
be effective in preventing neuroinflammation, tau hyper-
phosphorylation, and behavioral impairments, triggered by 
Aβ in vivo.118
Activation of the Nrf2 signaling pathway
One of the elegant mechanisms that neuronal cells have adapted 
to protect themselves against oxidative stress and other insults 
is Nrf2 pathway and the binding of this master transcriptional 
regulator with ARE in the regulatory region of many genes, 
which leads to the expression of several enzymes with anti-
oxidant and detoxification capacities (Figure 5).178 The main 
enzymes that are transcribed under the control of ARE include 
γ-glutamylcysteine synthetase, glutathione peroxidase, gluta-
thione S-transferase, HO-1, NADPH quinine oxidoreductase 1, 
peroxiredoxin, sulfiredoxin, thioredoxin, and thioredoxin 
reductase all of which have important roles in the protection 
of cells.179–181 The pivotal finding that Nrf2-knockout mice 
exhibit a severe deficiency in the coordinated regulation of 
gene expression and their susceptibility to oxidative damage 
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Figure 5 Polyphenols activate Keap1/Nrf2/ARE pathway and increase the expression of detoxification/antioxidant enzymes.
Notes: In the cytoplasm, Keap1 protein is always bound to Nrf2 transcription regulator and prevents its signaling. Polyphenols directly or indirectly cause dissociation 
of Nrf2–Keap1 complex and subsequent nuclear translocation of Nrf2. In the nucleus, Nrf2 binds to the ARE in the regulatory region of the target genes and stimulates 
transcription of detoxification/antioxidant enzymes HO-1, GCL, GPx, GST, SOD, CAT, PRX, and Trx.
Abbreviations: ARE, antioxidant response element; CAT, catalase; EGCG, epigallocatechin–gallate; ERK, extracellular signal-regulated kinase; GCL, γ-glutamylcysteine 
synthetase; GPx, glutathione peroxidase; GST, glutathione S-transferase; HO-1, heme oxygenase-1; Nrf2, Nuclear factor E2-related factor 2; PKC, protein kinase C; PRX, 
peroxiredoxin; SOD, superoxide dismutase; Trx, thioredoxin.
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indicate the crucial role of Nrf2 in maintaining intracellular 
redox homeostasis and antioxidant defense mechanism.182 The 
role of this pathway and the detoxification enzymes that it regu-
lates has been especially emphasized in CNS diseases.181
Some phenolic compounds such as luteolin64 and puerarin82 
in PC12 cells and also CAPE in dopaminergic neurons117 
enhance the binding of Nrf2 to ARE and increase the expres-
sion of HO-1. In cultured neurons, EGCG was able to protect 
cells against oxidative stress by increasing HO-1 expression 
via activation of the transcription factor Nrf2.183 Li et al184 
evaluated the neuroprotective effect of puerarin on lesioned 
substantia nigra induced by 6-OHDA. Their findings showed 
that puerarin effectively protects neurons in substantia nigra by 
modulating brain-derived neurotrophic factor (BDNF) expres-
sion and also by activating the Nrf2/ARE pathway.115 Carnosic 
acid and common sage (Salvia officinalis) plants also showed 
neuroprotective effects by activating Nrf2 in PC12h cells.184
Polyphenols and activation of other 
neurotrophic pathways
Polyphenols having multiple beneficial effects on the ner-
vous system could provide an important resource for the 
development of new drugs for management of neurodegen-
erative diseases. In addition to the aforementioned signaling 
pathways involved in the neurotrophic action of polyphenols, 
other mechanisms may also be involved. Daidzein has caused 
significant axonal outgrowth via upregulation of GAP-43 
expression in hippocampal neurons in culture. Interestingly, 
daidzein-promoted phosphorylation of PKC, and GAP-43 
was abolished by pretreatment with ER and PKC antagonist. 
These results suggest that ER-mediated PKC phosphoryla-
tion of GAP-43 may play a role in daidzein-mediated axonal 
outgrowth.80 Hesperetin can also exhibit multiple neurotrophic 
effects via ER- and TrkA-mediated parallel pathways.153
The Na+/K+/2Cl cotransporter (NKCC) is a member of 
the cation–chloride cotransporter family and is involved 
in the transport of chloride ion(s) coupled with cation(s) 
across the plasma membrane.185 A previous study has shown 
that NGF treatment of PC12D cells increased the expres-
sion of NKCC1 protein.186 In another report, it has been 
demonstrated that knockdown of NKCC1 strongly inhibits 
NGF induced-neurite outgrowth in PC12 cells. Interestingly, 
quercetin also promoted NGF-induced neurite outgrowth 
by increasing Cl-, and knockdown of NKCC1 inhibited this 
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stimulatory effect. In these cells, intracellular Cl- affects 
microtubule polymerization via modulation of intrinsic 
GTPase activity of tubulin.187
A2A subtype of adenosine receptors has been reported to 
elevate the expression of BDNF as well as synaptic actions 
of BDNF.188,189 This receptor also activates TrkB receptor 
and Akt signaling pathway, which induces neuronal survival 
and modulates neurite outgrowth in several different cell 
types.190–192 Jeon et al114 have recently shown that oroxylin 
A could induce BDNF production in cortical neurons via 
activation of A2A receptor, which induced cellular survival, 
synapse formation, and neurite outgrowth. In another report, 
the adenosine A2A receptor inhibitor could block methyl 
3,4-dihydroxybenzoate-induced neuronal survival and neu-
rite outgrowth in cultured primary cortical neurons.147
Conclusion
Polyphenols with multiple beneficial effects in the nervous 
system could provide an important resource for the discov-
ery of new neurotrophic agents. Agonistic action on Trk 
receptors, activation of the ERK, PI3Kinase/Akt and CREB 
pathways, activation of the Nrf2 pathway and upregulation 
of antioxidant and detoxification enzymes, as well as several 
other mechanisms underlie the neurotrophic action of differ-
ent polyphenols. A better understanding of the neurotrophic 
effects and the molecular mechanisms of action of these 
compounds could help design better agents for management 
of neurodegenerative diseases and other disorders of the 
nervous system.
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